Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Notes Payables (2024 - 2025)

Mangoceuticals' Notes Payables history spans 2 years, with the latest figure at $100000.0 for Q3 2025.

  • For Q3 2025, Notes Payables changed N/A year-over-year to $100000.0; the TTM value through Sep 2025 reached $100000.0, changed N/A, while the annual FY2024 figure was $150000.0, N/A changed from the prior year.
  • Notes Payables for Q3 2025 was $100000.0 at Mangoceuticals, down from $500000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $500000.0 in Q2 2025 and bottomed at $87500.0 in Q1 2024.